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Super-enhancers (SEs) are large clusters of tran-
scriptional enhancers that are co-occupied by multi-
ple lineage-specific transcription factors driving
expression of genes that define cell identity. In em-
bryonic stem cells (ESCs), SEs are highly enriched
for the core pluripotency factors Oct4, Sox2, and
Nanog. In this study, we sought to dissect the molec-
ular control mechanism of SE activity in pluripotency
and reprogramming. Starting from a protein interac-
tion network surrounding Sox2, we identified Tex10
as a key pluripotency factor that plays a functionally
significant role in ESC self-renewal, early embryo
development, and reprogramming. Tex10 is enriched
at SEs in a Sox2-dependent manner and coordinates
histone acetylation and DNA demethylation at SEs.
Tex10 activity is also important for pluripotency and
reprogramming in human cells. Our study therefore
highlights Tex10 as a core component of the pluripo-
tency network and sheds light on its role in epige-
netic control of SE activity for cell fate determination.
INTRODUCTION
Transcription factors (TFs) regulate tissue-specific gene expres-
sion programs through interactions with enhancer elements
(Buecker et al., 2014). Compared with typical enhancers (TEs),
super-enhancers (SEs) are large clusters of transcriptional en-
hancers that drive expression of genes that define cell identity.
In ESCs, SEs are highly enriched for Oct4, Sox2, and Nanog
(OSN) (Whyte et al., 2013) and express a group of non-coding
RNAs known as eRNAs (Lam et al., 2014), although the mecha-nisms by which pluripotency factors regulate SE activity and
eRNA transcription are not well defined. Enhancer activation
requires the presence of multiple lineage-specific TFs and
TF-recruited coactivators such as CBP/p300 (Chen et al.,
2008), which together help to establish the histone marks of
active enhancers such as H3K4me1 and H3K27ac. Active en-
hancers are also bound by general TFs and RNA polymerase II
(Pol II), leading to the production of eRNAs in SEs, and to a
lesser extent, in TEs (Hnisz et al., 2013). The eRNAs are tran-
scribed from Tet-occupied, hypomethylated enhancers (Pula-
kanti et al., 2013) and are able to mediate gene activation (Lam
et al., 2014). It is poorly defined how pluripotency TFs and their
associated cofactors may transcriptionally regulate the expres-
sion of SE eRNAs to maintain the pluripotent identity of ESCs.
Studies of Nanog (Costa et al., 2013; Wang et al., 2006) and
Oct4 (Ding et al., 2012; Pardo et al., 2010; van den Berg et al.,
2010) interactomes in ESCs have led to the discovery of many
novel pluripotency TFs and associated epigenetic regulators
(Huang and Wang, 2014) that play important roles in maintaining
pluripotency and promoting reprogramming. In contrast, studies
of Sox2-associated protein complexes have only been per-
formed in early differentiating ESCs (Mallanna et al., 2010) or in
a transgenic ESC line expressing all four ‘‘Yamanaka reprogram-
ming factors’’ (Gao et al., 2012), leaving it an open question of
whether the bona fide Sox2 interactome has been identified.
Consequently, additional transcription cofactors and/or epige-
netic regulators that are required for Sox2 to target and exert
transcriptional regulation of target genes remain to be defined.
Whereas Sox2 co-occupies ESC TEs and SEs with Nanog,
Oct4, and Mediator in maintaining ESC identity (Hnisz et al.,
2013; Kagey et al., 2010; Whyte et al., 2013), it directly interacts
only with Nanog (Gagliardi et al., 2013) while relying on DNA for
its Oct4 association (Lam et al., 2012). Sox2 binds first to the pre-
dominant Sox2/Oct4 co-binding motif, defined as the Sox-Oct
enhancer, which is followed by assisted binding of Oct4 during
the enhanceosome assembly in ESCs (Chen et al., 2014).Cell Stem Cell 16, 653–668, June 4, 2015 ª2015 Elsevier Inc. 653
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Figure 1. Identification of Wdr18, Tex10, and Las1L as Novel Partners of Sox2
(A) All proteins (one dot shows one protein) are shown by combined cumulative probability (CCP) scores and FDR q values.
(B) List of 23 preys with highest CCP scores. The proteins were selected by a cut-off of q < 0.10 and CCP > 10.5.Validated interactions by a previous study (Gao
et al., 2012) or in this study by IP/co-IP are shaded in gray. Wdr18, Tex10, and Las1L are in bold text.
(C) Gene expression of Wdr18, Tex10, and Las1L during EB differentiation. Microarray data are from GEO: GSE3749. The scale represents fold changes.
(D) Gene expression of Wdr18, Tex10, and Las1L during somatic cell reprogramming. Microarray data are from GEO: GSE19023. The scale represents fold
changes.
(E) Validation of physical associations of Wdr18, Tex10, and Las1L with Oct4, Sox2, and Nanog by co-IP in J1 ESCs.
(legend continued on next page)
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Interestingly, endogenous Sox2 is also hierarchically activated
first in the deterministic stage of reprogramming and plays an
important role in orchestrating downstream pluripotency gene
activation, including that of Oct4 and Nanog, during the estab-
lishment of pluripotency (Buganim et al., 2012; Polo et al.,
2012). Therefore, identification of additional Sox2 cofactors
and epigenetic regulators that play critical roles in pluripotency
and reprogramming will greatly facilitate a better understanding
of Sox2-guided enhanceosome assembly in ESCs, and in partic-
ular, SE control for the pluripotent cell identity.
We employed immunoprecipitation (IP) for affinity purification
of Sox2 protein complexes in ESCs combined with mass spec-
trometry (MS) to construct an extended Sox2 interactome for
identification of such important factors. Here we report our dis-
covery of Tex10 as a bona fide Sox2 partner and critical plurip-
otency factor with a unique mode of action in controlling SE
activity via modulating DNA methylation and histone acetylation
for stem cell maintenance, somatic cell reprogramming, and
early embryogenesis. Specifically, we found that Tex10 is criti-
cally required for both maintenance of ESCs and establishment
of pluripotency during early embryogenesis and somatic cell
reprogramming. Mechanistically, Tex10 recruits the coactivator
histone acetyltransferase p300 and cooperates with DNA
hydroxylase Tet1 for epigenetic modifications of the SEs
associated with pluripotency gene loci. Consequently, H3K27
acetylation and hypomethylation of SEs lead to enhanced
eRNA transcription and positive regulation of pluripotency
gene expression. Finally, we demonstrate the functional conser-
vation of this key pluripotency factor in both mouse and human
pluripotency.
RESULTS
The Sox2 Interactome Identifies Tex10 as an Interacting
Partner of Sox2
Following our well-established protocols (Costa et al., 2013;
Ding et al., 2012) for affinity purification in mouse ESCs (Figures
S1A–S1E, and see Experimental Procedures for details) and em-
ploying an iPAC algorithm for interactome analysis (see Supple-
mental Experimental Procedures for details), we identified 67
high confidence Sox2-interacting proteins (Table S1; Figures
1A and S1F). These contain many TFs, RNA processing factors,
protein folding factors, epigenetic regulators, and others (Fig-
ure S1F). The top 23 proteins as the highest confidence candi-
dates for Sox2 partners are identified with the most stringent
cut-off false discovery rate (FDR) and combined cumulative
probability (CCP) scores (Figure 1B and see Supplemental
Experimental Procedures). These include factors whose interac-
tions with Sox2 were either previously reported (e.g., Xpo4; Gon-
tan et al., 2009) or newly confirmed (e.g., Chd7; Figure S1G)
(shaded gray in Figure 1B). Our Sox2 interactome contains
both documented (e.g., NuRD proteins) and potentially novel
(see below) ESC regulators that play important roles in pluripo-(F) Validation of the endogenous interaction between Sox2 and Tex10 by Tex10
(G) Validation of the Sox2-Tex10 interaction by Tex10 antibody-based IP in ESC
(H) Immunofluorescence staining of Tex10 (red) and FLAG (green) in J1 and T10F1
with DAPI (blue).
See also Figure S1.tency (Hu and Wade, 2012) and reprogramming (Dos Santos
et al., 2014; Rais et al., 2013).
We were particularly interested in the newly identified Sox2
partners Wdr18, Tex10, and Las1L for several reasons. First,
all three factors are often co-purified as part of the 5FMC (five
friends of methylated Chtop) (Fanis et al., 2012), MLL1/MLL
(Dou et al., 2005), and Rix (Castle et al., 2012) complexes in other
cellular systems, which play such important roles as linking argi-
nine methylation to desumoylation for transcriptional regulation,
modifying H3K4 methylation, and controlling ribosome biogen-
esis and cell cycle regulation through p53, respectively. Cell
cycle control has been intrinsically linked with pluripotency and
reprogramming (Hindley and Philpott, 2013) and ribosome
biogenesis is being recognized for its potential role in controlling
pluripotency and reprogramming (Fong et al., 2014) and germ-
line stem cell fate (Zhang et al., 2014). Second, they are all highly
enriched in ESCs and are downregulated during embryoid body
(EB) differentiation (Figure 1C) or in non-pluripotent cells (Fig-
ure S1I). Third, they are all upregulated during the generation
of induced pluripotent stem cells (iPSCs) (Figure 1D). Such
expression patterns mimic those of the core pluripotency factors
OSN (Figures 1C and 1D). Fourth, all three factors interact with
Sox2 and Nanog, but less likely with Oct4 (Figures 1E and
S1J), which is consistent with them being Sox2 partners and
the association of Sox2 with Nanog being direct (Gagliardi
et al., 2013), whereas the association with Oct4 is DNA depen-
dent (Lam et al., 2012). Taken together, our data and published
studies suggest that these three factorsmay play important roles
in controlling pluripotency and reprogramming.
In summary, we have established an extended Sox2 interac-
tome and identified 23 high confidence Sox2 partners that
have known or potential roles in controlling pluripotency and re-
programming. Our study thus provides a rich resource for further
dissecting Sox2-guided enhanceosome assembly and particu-
larly the dynamic control of SE activity for the pluripotent cell
identity in ESC maintenance and iPSC generation.
Tex10 Is Required for Self-Renewal and Pluripotency
of ESCs
We focused on Tex10 to dissect the dynamic control of Sox2-
guided enhanceosome assembly and understand its roles in
pluripotency and reprogramming. We first confirmed the endog-
enous interaction between Tex10 and Sox2 (Figures 1F and 1G
and S1H) and demonstrated that Tex10 is a nuclear protein high-
ly expressed in ESCs (Figure 1H), although mRNA expression
levels are also enriched in several adult mouse tissues such as
testis, uterus, and lung (Figure S1K). We then performed loss-
of-function experiments to study the potential roles for Tex10
in ESC maintenance. Downregulation of Tex10 with two inde-
pendent shRNAs (Figure 2A) resulted in the reduction of total col-
ony number and size with an increased proportion of partially
and fully differentiated populations and reduced alkaline phos-
phatase (AP) activity (Figures 2B and 2C), indicating the loss ofantibody-based IP in CCE ESCs.
s expressing the FLBIOSox2 transgene.
0 (J1with ectopic 3xFLTex10 expression) ESCs. Cell nuclei were counter-stained
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Figure 2. Tex10 Is Required for ESC Maintenance
(A) Quantitative PCR analysis of Tex10 expression after 4 days of Tex10 knockdown. Data are presented as mean ± SEM (n = 3).
(B) Morphology of Tex10 knockdown ESCs with (bottom) or without (top) AP staining.
(C) Colony formation assay for ESCs with luciferase (Luci) knockdown or Tex10 knockdwon. Individual colonies were stained for AP activity and scored into three
categories (UD, uniformly undifferentiated; PD, partially differentiated or mixed; and D, differentiated) as indicated.
(legend continued on next page)
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self-renewal. Consistent with this, Tex10-depleted ESCs grew
slower than control ESCs (Figure 2D) due to an elongated G1
phase (Figure 2E) and not to apoptosis (Figure S2A). Such a
defect in self-renewal can be rescued by ectopic expression of
a Tex10 transgene that lacks the shRNA target site, excluding
off-target effects of the shRNAs (Figures S2B and S2C). Of
note, a similar requirement of the core pluripotency factors
OSN for efficient G1/S transition in both human (Card et al.,
2008; Zhang et al., 2009) and mouse (Schoeftner et al., 2013)
ESCs has also been reported, suggesting a potential functional
interaction between Tex10 and OSN.
To further understand how Tex10 regulates self-renewal at
the molecular level, we performed RNA-seq analyses in control
luciferase knockdown and Tex10 knockdown cells, which led to
the identification of 1,869 and 2,109 genes that are downregu-
lated and upregulated, respectively, upon Tex10 depletion (Fig-
ures 2F and S2D). More importantly, the downregulated and
upregulated genes correspond to those that are highly enriched
in ESCs and differentiated cells of multiple lineages including
the trophoblast lineage (Figures S2D–S2F). Supporting the
fact that Tex10 may globally intersect with the pluripotency
transcription network for ESC maintenance, we found a close
correlation of the transcriptomic changes upon Tex10 depletion
with those upon depletion of other pluripotency factors in-
cluding OSN, Esrrb, and Tbx3 (Figure 2G, yellow square).
In addition, Tex10 depletion reduced the expression of ESC-en-
riched genes as well as the targets of OSN (Figure 2H).
Finally, the global expression profile induced by Tex10 knock-
down is significantly similar to that resulting from Sox2
depletion (Figure 2I), further confirming that Tex10 not only
physically but also functionally interacts with Sox2 in maintain-
ing pluripotency.
Together, our data indicate that Tex10 is a previously unappre-
ciated factor that functionally intersects with the core pluripo-
tency network for optimal self-renewal and pluripotency of
ESCs, establishing Tex10 as a key pluripotency factor.
Tex10 Is Required for Early Mouse Development
We reasoned that Tex10 as a key pluripotency factor must also
be critical for mouse early development. Single-cell transcrip-
tomic analysis of early mouse embryos (Tang et al., 2011) re-
vealed that Tex10mRNA is upregulated during embryonic devel-
opment from oocyte to inner cell mass (ICM) stages, although it
is also expressed in trophectoderm and slightly downregulated
in epiblast (Figure 3A). Established ESCs have further enhanced
Tex10 expression (Figure 3A). Such an expression pattern during
early embryo development was further confirmed by LacZ stain-
ing of Tex10 heterozygous mouse embryos harboring a gene
trap allele (Figure S3A) at corresponding stages (Figure 3B).(D) Growth curve analysis of Tex10-depleted ESCs. Luciferase knockdown (shLu
(E) Cell cycle analysis of Tex10-depleted ESCs. Luciferase knockdown (shLuci) s
(F) Scatter plot of the RNA-seq expression data from luciferase and Tex10 knock
(G) Hierarchical clustering of pluripotency factors based on transcriptome chan
correlation coefficient (R).
(H) Gene set enrichment analysis of the RNA-seq data from luciferase and Tex10 k
the targets of Nanog, Sox2, and Oct4 (Ang et al., 2011; Lee et al., 2012) are use
(I) Gene set enrichment analysis of the RNA-seq data from luciferase and Tex10 kn
Sox2 knockout (GEO: GSE5895) are used.
See also Figure S2.Consistent with the biochemical evidence on the Sox2-Tex10
partnership (Figure 1), we also found co-localization of these
two proteins in mouse blastocysts (Figure 3C), supporting the
physical and functional connection of Tex10 and Sox2 both
in vitro and in vivo.
To directly test the function of Tex10 during early embryo
development, we injected siRNA against Tex10 (siTex10)
and non-targeting control (siNon) into wild-type (from mating
C57Bl/6J with C57Bl/6J3DBA/2J, or B6D2) mouse zygotes
and then cultured those embryos in vitro. We found that deple-
tion of Tex10 significantly reduced the embryo development
from morula to blastocyst stage (Figures 3D and 3E and
S3B). We confirmed efficient knockdown of Tex10 and also
noticed a reduction of Sox2 expression as well as upregulation
of p53 and its direct downstream target p21 (Figure 3F). A
similar effect of Tex10 depletion on Sox2, p53, and p21 was
also observed in ESCs at both the protein (Figure S2G) and
transcript (Figures 2F and S2H) levels. Since knockdown of
p53 only partially rescues the defects of cell cycle, proliferation,
and self-renewal of Tex10-depleted ESCs (Figures S2I–S2L),
we believe that a combined effect of downregulation of
pluripotency genes (e.g., Sox2) and upregulation of p53 and
p21 may have contributed to compromised early embryo
development.
To further investigate the role of Tex10 during mouse develop-
ment, we created a Tex10 knockout mouse model by using
Tex10+/LacZ ESCs (Figures S3A and S3C). We successfully ob-
tained heterozygous males and females that are phenotypically
normal with a regular life span. Among 95 pups generated from
matings between heterozygous males and females, we obtained
25 wild-type and 70 heterozygous Tex10+/LacZ mice, but no ho-
mozygous mutants (Tex10LacZ/LacZ) (Figure 3G), indicating that
Tex10 homozygous pups may have died before birth. We thus
performed early embryo analyses by examining 39 decidual
swellings obtained at mid-gestation 7.5 dpc, among which we
found 15 empty deciduas, 6 wild-type embryos, and 16 hetero-
zygous embryos, as well as 2 embryos of unknown genotype
(with such a designation due to limited material) (Figure 3H).
These data suggest that Tex10 knockout is likely early embryonic
lethal prior to 7.5 dpc, which is consistent with our siRNA exper-
iment demonstrating the morula-to-blastocyst arrested pheno-
type (Figures 3D and 3E and S3B). To further corroborate this,
we attempted to derive ESCs from 3.5 dpc blastocysts obtained
from heterozygous matings (Figure S3C). A total of 54 blasto-
cysts were obtained for outgrowth following standard protocol
(Meissner et al., 2009), among which 27 colonies were grown
out and the other half failed to grow due to technical diffi-
culties and/or presumed mutant consequences. Among the 27
outgrown colonies, 17 were stably established for genotypingci) serves as a control. Data are presented as mean ± SEM (n = 3).
erves as a control.
down ESCs.
ges upon depletion of each individual factor. The scale represents a Pearson
nockdown ESCs. Sets of the ESC-enriched genes (Ben-Porath et al., 2008) and
d.
ockdown ESCs. Sets of the downregulated and upregulated genes at 72 hr after
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Figure 3. Tex10 Plays Critical Roles in the Establishment of Pluripotency In Vivo and In Vitro
(A) Tex10 expression during early embryonic development based on published dataset (GEO: GSE22182). ICM, inner cell mass; TrE, trophectoderm.
(B) X-gal staining of early embryos. The gene trap allele of Tex10 expressing LacZ was depicted in Figure S3A.
(C) Immunofluorescence staining of LacZ (driven by the Tex10 promoter) (green) and Sox2 (red) in two overlapping blastocysts. Cell nuclei were counter-stained
with DAPI (blue). ICM is encircled with a dotted line for each blastocyst.
(D) Effect of Tex10 knockdown on blastocyst development. Zygotes were arbitrarily separated into three groups and processed in parallel for siRNA treatments
and morphological examinations. Morphology of embryos 4.5 days after siRNA injection is shown. The normal developing blastocysts are shown in red
rectangles.
(legend continued on next page)
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(Figures 3I and 3J), revealing 5 wild-type and 12 heterozygous
(Figure 3I) lines of typical ESC colony morphology (Figure 3J,
left and middle panels). The remaining 10 initially grew but then
could not be further propagated for genotyping and were pre-
sumed mutants (Figure 3J, the right panel). These results sug-
gest that Tex10 null embryos may not develop to the blastocyst
stage and/or that mutant blastocysts are defective for in vitro
ICM outgrowth.
Together, our data functionally define Tex10 as a key pluripo-
tency factor that is essential for early development, although the
exact cause of early embryonic lethality of Tex10 knockouts and
its potential roles in trophectoderm (Figures 3A–3C) and testis
(Figure S1K) remain the subject for future investigation with a
conditional null allele.
Tex10 Is Required for Efficient Somatic Cell
Reprogramming
We explored the potential roles for Tex10 in the establishment of
pluripotency during somatic cell reprogramming. We first tested
knockdown or ectopic expression of Tex10 in conventional
Yamanaka reprogramming of mouse embryonic fibroblasts
(MEFs) (Figure S3D). Like Sox2, Tex10 is activated during the
late stage of reprogramming (Figure 3K). Consistent with the
crucial roles of Sox2 in orchestrating the transcriptional activa-
tion hierarchy at this stage (Buganim et al., 2012; Polo et al.,
2012), we found that knockdown of Tex10 (Figure 3L), a close
partner of Sox2, also dramatically decreased MEF reprogram-
ming efficiency (Figure 3M). This reprogramming defect upon
Tex10 depletion is minimally attributed to decreased MEF prolif-
eration (Figures S3E and S3F), but more likely to a combinatorial
effect of compromised mesenchymal-to-epithelial transition
(Figures S3H–S3J) and the reduced reactivation of pluripotency
genes during reprogramming (Figure S3K). Conversely, ectopic
expression of Tex10 enhanced the reprogramming efficiency
by 6-fold (Figure S3G), although it cannot replaceSox2 in reprog-
ramming (data not shown).
To directly address Tex10 function in the final stage of reprog-
ramming, we employed the Nanog-driven pre-iPSC reprogram-
ming system (Silva et al., 2008) (Figure S3L). Like Sox2, Tex10 is
also activated at the final stage during pre-iPSC reprogramming
(Figure S3M). Depletion of Tex10 reduced Nanog-driven reprog-
ramming efficiency compared with the empty vector control as
measured by Oct4-GFP-positive colony numbers (Figure S3N).
Together with the data presented in Figure 2, our study estab-
lishes a critical role of Tex10 for both themaintenance and estab-
lishment of pluripotency in vitro and in vivo.(E) Relative quantitation of normal embryos at each developmental stage. Values
independent groups shown in (D).
(F) Gene expression analysis by RT-qPCR in the siTex10-injected morulas relative
as mean ± SEM (n = 3).
(G) Table summarizing the live born litter and Mendelian ratio of mice from Tex10
(H) Table summarizing 7.5 dpc embryos from Tex10+/ 3 Tex10+/ matings. U.D
(I) Table summarizing genotypes and Mendelian ratio of established ESC lines fr
(J) Morphology of established ESCs as summarized in (I).
(K) Expression of Tex10 and Sox2 during MEF reprogramming. Data are present
(L) Knockdown efficiency of Tex10 shRNA in MEFs.
(M) Compromised reprogramming efficiency of MEFs upon Tex10 depletion comp
positive colony numbers from two independent experiments are shown.
See also Figure S3.Tex10 Positively Regulates SE Activity
To understand the molecular mechanisms by which Tex10 reg-
ulates pluripotency, we identified global genomic targets of
Tex10 by chromatin IP (ChIP)-seq in ESCs ectopically express-
ing 33FLAG-tagged Tex10. Owing to the lack of a ChIP-grade
Tex10 antibody, FLAG antibody-based ChIP was performed
and specific enrichment of Tex10 in FLAG ChIPed samples
was confirmed by Tex10 western blot, validating the FLAG
ChIP for detecting Tex10 binding DNA fragments (Figure S4A).
A total of 5,189 Tex10 binding regions (peaks) were identified,
among which 47.8%, 32.3%, and 19.9% of peaks are localized
in promoters, intergenic regions, and gene bodies, respectively
(Figure 4A). Consistent with the high percentage of promoter oc-
cupancy, Tex10 peaks are enriched at transcription start sites
(TSSs) (Figure S4B). Since Tex10 is physically associated with
Sox2, as expected, we found that 46% of Tex10 targets are
also bound by Sox2 (Figure S4C) and that the Tex10 binding
motif (de novo) is significantly similar to the Sox2 binding
consensus motif (Figure S4D; p = 10238). Such a strong correla-
tion of genomic localization with Sox2 was shared by other plu-
ripotency factors such as Nanog, Oct4, Med1/12, and Esrrb (Fig-
ure S4E). We also found Tex10 clustered together with OSN and
Med1/12 at a global level in target gene occupancy (Figure S4F,
red and green rectangles). Combined with the RNA-seq data
(Figure 2F), we found that Tex10 knockdown significantly
reduced the expression of the genes within 5 kb of Tex10 binding
regions (Figure S4G), indicating that Tex10 is a positive regulator
of gene expression in ESCs. These results strongly support that
Tex10 is an integral part of the core pluripotency network en-
compassing OSN that governs the ESC identity.
Active ESC enhancers are often co-occupied by multiple core
pluripotency factors including OSN and are marked with high
levels of H3K4me1 and H3K27ac in combination with a low level
of H3K4me3 (Creyghton et al., 2010; Kagey et al., 2010). Interest-
ingly, we found that Tex10 binding regions are also enriched for
OSN (Figure 4B) as well as the active enhancer marks (H3K4me1
and H3K27ac) (Figure 4C), suggesting that Tex10, as a close
partner of Sox2, may play a role in Sox2-guided enhanceosome
assembly regulating enhancer activity in ESCs. We selected the
enhancers by these histone marks and beyond 3 kb of TSS,
revealing that Tex10 is indeed enriched at enhancer regions (Fig-
ure 4D). While Tex10-only binding regions are low in H3K4me1
(Figure 4E; blue bars) and high in H3K27ac (Figure 4E; yellow
bars), Tex10 and Sox2 co-binding regions are greatly enriched
for the combination of both marks (H3K4me1+H3K27ac) (Fig-
ure 4E, red bars), suggesting a Sox2-dependent function ofwere normalized to the two-cell stage and plotted as mean ± SEM from three
to siNon controls. Expression is normalized by Gapdh and data are presented
+/ 3 Tex10+/ matings.
., undetermined.
om outgrowth of blastocysts derived from Tex10+/ 3 Tex10+/ matings.
ed as mean ± SEM (n = 3).
ared with luciferase knockdown. AP staining (left) and quantitation (right) of AP-
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Figure 4. Tex10 Positively Regulates SE Activity with Sox2 in ESCs
(A) Distribution of Tex10 binding sites at promoter (3 to +3 kb), gene body, and intergenic regions.
(B) Average ChIP-seq read density of Tex10, Sox2, Oct4, and Nanog near the Tex10 peak center.
(C) Average ChIP-seq read density of Tex10, H3K4me1, and H3K27ac near the Tex10 peak center.
(D) Tex10 binding regions are enriched for enhancers.
(E) Histograms showing percentage of genomic regions in ESC enhancer and Tex10 (only or shared with Sox2) and CTCF ChIP-seq peaks overlapping with
H3K4me1 (K4me1), H3K27ac (K27ac), or both (K4me1+K27ac) peaks.
(F) Heatmaps of Tex10 binding loci are sorted by the enhancer mark H3K4me1 and the active promoter mark H3K4me3. H3K27ac is an active mark for both
enhancers and promoters. ESC-specific enhancers are co-bound by Sox2, Oct4, Nanog, and Med1.
(legend continued on next page)
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Tex10 in regulating ESC enhancer activity (see below).We sorted
Tex10 peaks by H3K4me1 and H3K4me3 to distinguish en-
hancers from promoters, and we found that the majority of
Tex10 enhancers and few Tex10 promoters are targeted by
OSN (Figures 4F and S4H), reinforcing the notion that Tex10
may contribute to Sox2 functions in regulating ESC-specific en-
hancers. Consistent with this, the genes near Tex10 enhancers
have higher expression than non-enhancer-associated genes
or the genes near enhancers regardless of Tex10 binding (Fig-
ure S4I), and Tex10 knockdown reduced the expression of the
majority of Tex10 enhancer-associated genes (Figure S4J).
ESC SEs are part of ESC-specific enhancers and have a larger
size, an increased ability to activate transcription, and height-
ened sensitivity to perturbation as compared to TEs. They are
also enriched for Med1 and cell-type-specific TFs, such as
OSN in ESCs (Whyte et al., 2013). The close relationship of
Tex10 with OSN and Med1 in target gene occupancy (Figures
4F and S4F) prompted us to investigate potential functions of
Tex10 in regulating SE activity. Previous studies identified 231
SEs according to the density of Med1 in ESCs (Whyte et al.,
2013). We found that 4,515 (87%) of Tex10 binding peaks,
including the majority of promoters and enhancers, are also
occupied by Med1 (Figures 4F and 4G and S4K). Like Med1,
Tex10 is also enriched in the regions of ESC SEs (Figures 4H
and 4I) and has a significantly stronger density in SEs than in
TEs (Figures 4J–4L and S4M). Correspondingly, comparison of
the expression changes between SE- and TE-associated genes
upon Tex10 knockdown revealed that SE-associated genes are
more sensitive to Tex10 depletion than TE-associated genes
are (Figure S4L). To address how Tex10 may regulate the
expression of SE-associated genes, we selected genes closest
to the SEs and examined their expression using RNA-seq data
(Figure 2F). Predictably, we observed that expression of most
Tex10 SE-associated genes was downregulated after Tex10
knockdown (Figure 4M). We further employed a luciferase re-
porter assay whereby the luciferase gene is driven by the ESC-
specific enhancer within the well-known SE in the Nanog locus,
and we confirmed that Tex10 can further enhance Oct4- and
Sox2-mediated enhancer activity (Figure S4M). Together our
data establish Tex10 as a positive regulator of SE activity in
ESCs.
Tex10 Regulates Epigenetic Modifications and eRNA
Transcription of SEs
We explored molecular mechanisms by which Tex10 positively
controls SE activity. Enhancer elements are pre-marked with
H3K4me1 followed by H3K27ac modification to generate an(G) Tex10 shares the majority of its targets with Med1.
(H) Distribution of Tex10, Med1, H3K4me1, and H3K27ac normalized ChIP-seq d
we normalized the plot by dividing the ChIP-seq signals by the maximum signals
(I) The heatmap of Tex10 and Med1 intensity at 231 ESC SEs.
(J) The heatmaps of Med1 and Tex10 both show that they are enriched in SE reg
(K) Box plot of Tex10 and Med1 ChIP-seq density (reads per million reads per bas
range. p values were calculated using a two-tailed t test.
(L) ChIP-seq binding profiles (reads per million per base pair) for the Tex10 and ES
models are depicted above the binding profiles. SE bar and scale bar are depict
(M) Relative expression of SE-associated genes in Tex10-depleted ESCs compa
selected. The scale represents fold changes.
See also Figure S4.open chromatin conformation for multi-factor co-occupancy
(Calo and Wysocka, 2013). Although Tex10 was reported to be
co-purified with MLL1/MLL complex in HeLa cells (Dou et al.,
2005), we did not identify MLL components in the Tex10 interac-
tome in ESCs (data not shown). In addition, we detected neither
global expression (Figure 5A) nor locus-specific H3K4me1
enrichment change upon Tex10 depletion (data not shown)
within the time window when ESCs still maintained undifferenti-
ated morphology and had minimal alteration of Oct4 and Sox2
expression under reduced Tex10 expression (Figure S5A). In
contrast, we found that Tex10 depletion reduced enrichment of
H3K27ac modifications in the SE regions of Oct4, Nanog, and
Esrrb loci (Figure 5B) in the presence of overall normal expres-
sion levels of H3K27ac (Figure 5A), suggesting that Tex10 may
regulate SE activity mainly through modulating histone acetyla-
tion. In line with this, we found that p300, the H3K27 acetyltrans-
ferase that is enriched at enhancer regions in ESCs (Chen et al.,
2008), is also highly enriched at Tex10 binding regions (Fig-
ure 5C), and that depletion of Tex10 caused reduced binding
of p300 to the SEs of Nanog, Oct4, and Esrrb loci (Figure 5D)
without altering overall p300 expression (Figure 5A). Our data
suggest that Tex10 may recruit p300 to the enhancer regions
to establish H3K27 acetylation and regulate SE activity.
To further understand how Tex10-mediated p300 action on
H3K27 acetylation and the resulting open chromatin of ESC en-
hancers may lead to target gene regulation, we asked what
other Tex10 cofactors and/or epigenetic regulators may be
recruited by Tex10 to ESC enhancers for transcriptional activa-
tion of enhancer-associated genes. To this end, we biochemi-
cally purified Tex10-interacting proteins in ESCs using the
SILAC (stable isotope labeling by amino acids in cell culture)
system coupled with IP-MS (see Supplemental Experimental
Procedures for details) and identified both Tet1 and Tet2 as
partners of Tex10 (Figures S5B and S5C). Further purification
of Tet1 protein complexes using SILAC IP-MS in ESCs also
identified Tex10 (Figure S5D). The Tex10-Tet1 interaction was
further confirmed by co-IP (Figure 5E). Like Tet1 (Wu et al.,
2011), Tex10 peaks are also highly enriched for CpG islands
(Figure S5E). Interestingly, Tet1 is also abundant in SE regions
(Figure 5F), and Tex10, Sox2, and Tet1 co-binding targets are
more enriched at enhancers than promoters and other regions
(Figure S5F). Furthermore, we found that 75% of Tex10 bind-
ing peaks are also occupied by Tet1 (Figure S5G), supporting
the physical and functional connection between Tex10 and
Tet1.
SEs are reported to be hypomethylated with Tet1 occupancy
(Pulakanti et al., 2013) and the enrichment of active enhancerensity across a subset of 8,794 ESC enhancers. For each ChIP-seq data point,
individually, and we sorted them in an ascending order.
ions.
e) at the SE and TE regions. Box plot whiskers extend to 1.53 the interquartile
C TFs Oct4, Sox2, and Nanog (OSN) andMed1 at theOct4 locus in ESCs. Gene
ed above the binding profiles.
red with luciferase knockdown ESCs. The genes that are closest to SEs were
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histone marks and DNA methylation density are anti-correlated
(Stadler et al., 2011). Currently, whether and how Tet1 may
mediate enhancer DNA demethylation and contribute to SE ac-
tivity in ESCs are not well defined.We thus explored the possibil-
ity that Tet1 may cooperate with Tex10 and Sox2 in modulating
the DNAmethylation status of enhancer elements. We examined
the levels of methylcytosine (5mC) and hydroxymethylcytosine
(5hmC) at Tex10 peaks, and we found that Tex10 peaks are en-
riched for Tet1 but devoid of 5hmC and 5mC (Figure S5H). We
also examined the levels of 5mC and 5hmC at Tet1 peaks sorted
by Tex10 intensity and again found that Tex10 peaks are devoid
of 5hmC and 5mC (Figure 5G). These data indicate that Tex10-
bound DNA regions are unmethylated. Interestingly, we noticed
that Sox2 and Tet1 shared peaks are enriched for either Tex10 or
5hmC (Figure S5I) and that Tet1 binding SEs and TEs have signif-
icantly lower levels of 5mC and 5hmC when they are also
targeted by Tex10 (Figure 5H). Depletion of Tet proteins signifi-
cantly induced 5mC accumulations at Tet1/Tex10 co-binding
SE and TE regions (Figure 5I). These analyses suggest that
Tex10 may induce active DNA demethylation through facilitating
DNA demethylase Tet1 accessibility to Tex10/Sox2 co-bound
targets. Supporting this, we found that depletion of Tex10
reduced the binding of Tet1, whose expression is maintained
within the time window tested (Figure S5A), to the SE regions
of Oct4 and Esrrb loci (Figure 5J) with a concomitant increase
in 5mC enrichment at the same regions (Figure 5K). Together,
these results establish a Tex10-dependent function of Tet1 in
binding to Tex10-occupied SEs and modulating methylation
status of SEs.
To correlate DNA demethylation of SEs with their transcrip-
tional activities, we examined transcription of eRNAs associated
with SEs based on the findings that (1) eRNAs are transcribed in
SEs (Hnisz et al., 2013); (2) eRNAs arise from hypomethylated,
Tet1-occupied genomic regions (Pulakanti et al., 2013); and (3)
eRNAs promote associated mRNA transcription by establishing
chromatin accessibility and tethering enhancer activity to the
transcriptional apparatus (Mousavi et al., 2013). We first exam-
ined transcription of SE-associated eRNAs before and after
Tex10 knockdown. We found that Tex10 knockdown decreased
the expression of a number of previously reported eRNAs in
ESCs (Pulakanti et al., 2013) including those associated with
Oct4 and Nanog (Figures 5L and S5J). Conversely, ectopicFigure 5. Tex10 Regulates the Modifications and eRNA Transcription o
(A) Protein expression levels of Tex10, H3K4me1, H3K27ac, H3, p300, and Gapd
(B) Impact of Tex10 depletion on H3K27ac occupancy at Oct4, Nanog, and Esrr
Tex10 depletion, and H3K27ac occupancy was determined by ChIP-qPCR. Data
(C) Average ChIP-seq read density of Tex10 and p300 near the Tex10 peak cent
(D) Impact of Tex10 depletion on p300 occupancy at Oct4, Nanog, and Esrrb SEs
depletion, and p300 occupancy was determined by ChIP-qPCR. Data are prese
(E) Validation of the Tex10-Tet1 interaction by co-IP in ESCs expressing 33FLAg
(F) Metagenes of Tet1 ChIP-seq density (reads per million per base pair) across
(G) Heatmaps showing that Tet1 peaks are separated by Tex10 and 5hmC/5mC
(H) Density of 5mC and 5hmC at Tet1 binding SE or TE regions.
(I) 5mC percentages of Tet1/Tex10 co-binding SEs or TEs at WT and TKO (Tet1/
(J) Tet1 enrichment in Oct4 and Esrrb SE regions after 68 hr of Tex10 knockdow
(K) 5mC enrichment in Oct4 and Esrrb SE regions after 68 hr of Tex10 knockdow
(L) eRNA expression of Oct4 and Nanog SEs after 4 days of Tex10 knockdown.
(M) eRNA expression of Nanog SE after overexpression of Tex10. Data are prese
See also Figure S5.expression of Tex10 increased transcription of those eRNAs
(Figures 5M and S5K).
Collectively, our studies establish Tex10 as a major player in
the ESC enhanceosome assembly that regulates the SE activity
and eRNA transcription by cooperating with p300 and Tet1 to
control the histone acetylation and DNA hypomethylation of
SEs, respectively. Our results on Tet1’s participation in the
Sox2-guided ESC enhanceosome assembly via its Tex10 asso-
ciation sheds new light on our understanding of Tet proteins in
modulating enhancer activity in ESCs (Hon et al., 2014; Lu
et al., 2014) (see more in Discussion).
Sox2 Directs Tex10 to a Subset of Shared
ESC-Specific SEs
Because Tex10 and Sox2 physically interact (Figure 1) and
sharemany targets at ESC-specific enhancer regions (Figure 6A),
and because a Sox2-dependent function of Tex10 in establish-
ing both active enhancer marks (H3K4me1+H3K27ac) was
observed (Figure 4E), we hypothesized that Sox2 may recruit
Tex10 to these enhancers. To test this hypothesis, we created
an ESC line (2TST10) by introducing a constitutive 33FLAG-
tagged Tex10 transgene into the 2TS22C ESC line (Masui
et al., 2007) that has both endogenous Sox2 alleles removed
and replaced with a doxycycline (Dox) suppressible Sox2 trans-
gene for stem cell maintenance (Figure 6B). After 14 hr of Dox
treatment, Sox2 protein was depleted to a low level, whereas
Oct4 and Nanog are maintained together with constitutive
FLAG-tagged Tex10 protein expression (Figure 6C). ChIP-
qPCR was performed to analyze Tex10 binding to the shared
target loci upon Dox treatment (i.e., depletion of Sox2), which re-
vealed that Tex10 binding decreased significantly after Dox
treatment atNanog,Oct4, and Sox2 loci (Figures 6D–6F) despite
its normal expression (Figure 6C). In contrast, Tex10 binding is
not affected by Sox2 depletion in the Tex10-only genomic loci
(Figures S6A–S6C). These data indicate that Sox2 directs
Tex10 to a subset of shared ESC SEs in controlling their
activities.
Functional Conservation of Human TEX10 in
Pluripotency and Reprogramming
To further address whether Tex10’s functions in pluripotency
and reprogramming are evolutionally conserved, we performedf SEs
h after 68 hr of Tex10 knockdown.
b SEs. CCE ESCs were treated with shRNA against Tex10 for 68 hr to induce
are presented as mean ± SEM (n = 3).
er.
. CCE ESCs were treated with shRNA against Tex10 for 68 hr to induce Tex10
nted as mean ± SEM (n = 3).
-tagged Tex10.
the 8,563 TEs and the 231 SEs.
enrichment.
2/3 triple knockout) ESCs.
n. Data are presented as mean ± SEM (n = 3).
n. Data are presented as mean ± SEM (n = 3).
Data are presented as mean ± SEM (n = 3).
nted as mean ± SEM (n = 3).
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Figure 6. Sox2 Recruits Tex10 to a Subset of SEs in ESCs
(A) Most Tex10/Sox2 shared peaks are enriched at enhancers.
(B) Schematic overview of the 2TST10 ESCs. EndSox2, endogenous Sox2 allele; DoxSox2, doxycycline repressible Sox2 allele.
(C) Protein levels after 14 hr of Dox treatment in 2TST10 ESCs.
(D–F) Dox treatment decreased the enrichment of Tex10 at the SEs of Nanog (D), Oct4 (E), and Sox2 (F). Data are presented as mean ± SEM (n = 3).
(G) Tex10 is integrated to the core pluripotency network through protein-protein or protein-DNA interactions. The gray arrows indicate protein-DNA interactions
only, whereas the black arrows indicate both protein-protein and protein-DNA interactions.
(H) Amodel depicting functions of Tex10 on the regulation of SE-associated genes. In the pluripotency state, Tex10 co-occupieswith Sox2/Med1 and recruits Tet1
and p300 to theSEs for DNAdemethylation and histone acetylation, leading to active eRNA/mRNA transcription. InTex10-depleted cells, Tet1 and p300 cannot be
recruited to the SEs, resulting in DNA hypermethylation and reducedH3K27ac enrichment at SEs and, consequently, the loss of SE activity and pluripotency gene
expression. For simplicity, other pluripotency factors known to be present in ESC SEs such as Nanog, Oct4, and Tet2 are omitted in the illustration.
See also Figure S6.
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Figure 7. Human TEX10 Plays Critical Roles
in Human Pluripotency and Reprogramming
(A) Knockdown efficiency of the shRNAs against
human TEX10 4 days after TEX10 knockdown.
Data are presented as mean ± SEM (n = 3).
(B) Morphology of hESCs upon luciferase and
TEX10 knockdown. Top, AP staining of hESCs;
bottom, phase contrast microscopy of hESCs.
(C) Expression of human pluripotency and lineage
markers in luciferase and TEX10 knockdown
hESCs. Data are presented asmean ± SEM (n = 3).
(D) Reprogramming efficiency of the human
BJ cells with luciferase or TEX10 depletion.
Representative AP-positive iPSC colonies and
quantitative data from three different experiments
were shown on top and bottom panels, respec-
tively.
(E) Proliferation of human BJ cells after TEX10
knockdown.loss-of-function studies of human TEX10 on hESC maintenance
and human iPSC (hiPSC) generation. Using independent
shRNAs targeting human TEX10 (Figure 7A), we found that
TEX10 depletion led to differentiation of hESCs with reduced
AP staining (Figure 7B), concomitant downregulation of pluripo-
tency genes NANOG, OCT4, SOX2, and TERT1, and upregula-
tion of lineage-specific genes (Figure 7C). These data demon-
strate a critical role of TEX10 for hESC maintenance. To test
whether TEX10 is also important for the establishment of human
pluripotency, we performed human iPSC generation from BJ
cells with conventional Yamanaka reprogramming factors. We
found that TEX10 depletion resulted in a decreased reprogram-
ming efficiency (Figure 7D) with minimal effects on BJ cell
proliferation (Figure 7E), supporting the functional significance
of human TEX10 in the establishment of human pluripotency.
Together these data establish the evolutionally conserved
function of Tex10/TEX10 in controlling both stem cell pluripo-
tency and somatic cell reprogramming.Cell Stem Cell 16, 653–DISCUSSION
Our study uncovered Sox2-dependent
functions of Tex10 in controlling ESC-
specific enhancer and particularly SE ac-
tivity through recruitment of the histone
acetyltransferase p300 and the DNA
demethylase Tet1 for the transcriptional
regulation of SE-associated eRNA and
mRNA expression. Although there likely
exist Sox2-independent functions of
Tex10 in promoter regulation (Figures
4A and S4H), we primarily focused on
dissecting the potential contribution of
Tex10 to Sox2-guided enhanceosome
assembly and in particular, SEs, due to
their prominent roles in maintaining plu-
ripotency. We have provided multiple
lines of evidence integrating Tex10 into
the core pluripotency network (Figure 6G)
for epigenetic control of SE activity andESC identity: Tex10 orchestrates histone H3K27 acetylation,
DNA demethylation, and eRNA transcription, as succinctly
summarized in a model (Figure 6H) and further discussed
below.
First, our transcriptome (Figure 2) and genomic binding (Fig-
ures 4 and S4) correlation analyses, together with the physical
association (Figure 1) between Tex10 and other pluripotency
factors, position Tex10 in the center of the previously defined
OSN triumvirate regulatory loop controlling pluripotency (Kim
et al., 2008) (Figure 6G).
Second, while ectopic Oct4 and Sox2 can modestly activate
the Nanog enhancer in HEK293T cells devoid of endogenous
Oct4 and Sox2, a further activation effect can be achieved
when Tex10 is combined with Oct4 and Sox2 (Figure S4M).
Our data indicate that Tex10 may function as an Oct4/Sox2 co-
activator by recruiting p300 to the SEs for induction of H3K27ac
(Figures 5A–5D), which leads to activated pluripotency gene
expression in ESCs.668, June 4, 2015 ª2015 Elsevier Inc. 665
Third, we established Tex10 function in regulating enhancer
activity through Tet1-mediated DNA demethylation. Studies
have suggested that Tet1 and Tet2 have distinct roles in control-
ling enhancer activity in ESCs (Hon et al., 2014; Huang et al.,
2014). It was also reported that active and initiated enhancers
are predominantly hypermethylated with concomitant transcrip-
tional downregulation of enhancer-associated genes in Tet TKO
ESCs (Lu et al., 2014). While 5hmC is abundant at both poised
and active enhancers in ESCs (Yu et al., 2012), our findings led
us to hypothesize that recruitment of Tet1 by Tex10may facilitate
active DNA demethylation of SEs. Supporting this hypothesis,
our data show that Tex10 depletion reduces Tet1 binding and in-
duces 5mC enrichment in Oct4 and Esrrb enhancers in undiffer-
entiated ESCs (Figures 5J and 5K). However, we cannot exclude
the possible contribution of Tet2 to the observed SE hypomethy-
lation due to the association of Tet2 with Tex10 (Figures S5B and
S5C). Nevertheless, hypermethylation of enhancer regions alone
cannot account for the loss of self-renewal and differentiation of
Tex10-depleted ESCs (Figures 2, S2, and 7) because Tet TKO
ESCs retain ESC characteristics (Dawlaty et al., 2014; Lu et al.,
2014). Rather, our study highlights the significant role of Tex10,
as a newly discovered core pluripotency factor, in orchestrating
multiple epigenetic regulatory events that together control
enhancer activity and pluripotent cell identity. Thus, depletion
of Tex10 can lead to enhancer decommissioning through a com-
bined action of loss of H3K27 acetylation and DNA hypermethy-
lation, and consequently, to the derailment of the pluripotency
program.
Fourth, our study identifies a critical component of the enhan-
ceosome assembly in ESCs, namely the Sox2-Tex10-Tet1 trium-
virate, that may directly contribute to the open chromatin and
hypomethylation status of SEs leading to active transcription of
eRNAs and mRNAs. Tex10 is a structured protein containing an
Armadillo-type fold, an Armadillo-like helical, and a type 2 HEAT
domain, which can be the interface for protein, DNA, and RNA
binding. Such a unique structure of Tex10 may have endowed
this key pluripotency factor with versatile functions in orches-
trating histone acetylation,DNAdemethylation, andeRNA regula-
tion to control SE activity and pluripotent cell identity. Dissection
of the structure-function relationship of Tex10 in ESCs and during
reprogramming is warranted for future investigation.
Finally, the evolutionally conserved function in pluripotency and
reprogramming (Figure7) further consolidates the statusofTex10/
TEX10 as a newly-arrived key player in the core pluripotency
network, although the potential caveat exists that the proliferation
defect of its depletionmay have partly contributed to the compro-
misedpluripotencyand reprogramming.Futurestudies indissect-
ing the mechanistic action of TEX10 in human cells should shed
new light on human pluripotency and provide additional means
to enhance optimal maintenance/derivation of hESCs/hiPSCs
for therapeutic application and regenerative medicine.
EXPERIMENTAL PROCEDURES
Additional experimental procedures are provided in the Supplemental Exper-
imental Procedures.
Affinity Purification of Sox2 Protein Complexes in ESCs
The ESC lines of J1, BirA (containingBirA-V5 transgene), and Sox2#7 (contain-
ing FLBIOSox2 and BirA-V5 transgene) were expanded to five large square666 Cell Stem Cell 16, 653–668, June 4, 2015 ª2015 Elsevier Inc.dishes (245 3 245 mm) and were used to prepare nuclear extracts as previ-
ously described (Ding et al., 2012). Three independent streptavidin (SA) and
one FLAG IP, followed by MS identification, were performed as described
(Costa et al., 2013; Ding et al., 2012) to identify bona fide Sox2-interacting pro-
teins in ESCs. To further improve the quality of the interactome, we also per-
formed endogenous Sox2 antibody-based IP in wild-type J1 ESCs followed
by MS identification. Details are given in the Supplemental Experimental
Procedures.
Generation of Tex10 Knockout Mouse Model
An ESC clone Tex10_AB8 harboring a LacZ knockin cassette at the
Tex10 locus resulting in a knockout allele was obtained from KOMP
Repository Knockout Mouse Project. To generate chimeric embryos, we in-
jected 10–12 Tex10 heterozygous ESCs into Balb/c (albino) E3.5 wild-type
blastocysts and surgically implanted them into 2.5dpcpseudo-pregnantSwiss
Webster female mice following standard procedures. The chimeras with >50%
black coat color were mated with C57Bl/6N wild-type mice to test germline
transmission. Details on genotyping, staged embryo analysis, and ESC
derivation are given in the Supplemental Experimental Procedures.
Mouse Embryo Collection and Microinjection
The embryo experiments were performed as previously described (Wang
et al., 2014) with modifications described in the Supplemental Experimental
Procedures.
ChIP Coupled with ChIP-qPCR
ChIP was performed as previously described (Lee et al., 2006).
Reprogramming Assays in Adult Neural Stem and MEF Cells
Reprogramming was performed as previously described (Costa et al., 2013).
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The accession number for the Tex10 ChIP-seq and RNA-seq data reported in
this paper is GEO: GSE66736.
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